Related Experiment Video
Updated: May 20, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Cryptosporidiosis in children following solid organ transplantation
Irit Krause1, Jacob Amir, Roxana Cleper
1Institute of Pediatric Nephrology, Schneider Children's Medical Center of Israel, Petah-Tiqva, Israel. ikrause@post.tau.ac.il
Insights
Cryptosporidium infection in pediatric solid organ transplant recipients can cause severe diarrhea and complications. Early diagnosis and prolonged nitazoxanide treatment (at least 14 days) are crucial for recovery.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Transplantation Medicine
Background:
- Cryptosporidium parvum is a common cause of diarrhea, typically self-limiting in healthy individuals.
- It can cause severe disease in immunocompromised patients, with limited data in pediatric solid organ transplant recipients.
- This study reports on 6 pediatric solid organ transplant recipients experiencing Cryptosporidium-induced gastroenteritis.
Purpose of the Study:
- To describe the clinical presentation and outcomes of Cryptosporidium infection in pediatric solid organ transplant recipients.
- To highlight the importance of timely diagnosis and appropriate treatment in this vulnerable population.
Main Methods:
- Retrospective review of gastroenteritis episodes in solid organ transplant recipients from January 2008 to August 2011.
- Identification of cases with positive Cryptosporidium antigen stool staining.
- Analysis of patient demographics, clinical symptoms, laboratory findings, treatment, and outcomes.
Main Results:
- Cryptosporidium was detected in 6 out of 57 (11%) gastroenteritis episodes in pediatric solid organ transplant recipients.
- Affected patients experienced prolonged diarrhea, fever, abdominal pain, and weight loss, with a mean symptom duration of 10.5 days before diagnosis.
- Complications included kidney function deterioration (5 patients), increased tacrolimus levels (5 patients), and abnormal liver enzymes (4 patients).
- All patients were hospitalized, received fluid replacement, and were treated with nitazoxanide; two experienced symptom recurrence after short therapy courses.
- All patients eventually recovered.
Conclusions:
- Routine testing for Cryptosporidium is recommended in solid organ transplant recipients presenting with diarrhea.
- Delayed treatment initiation can lead to serious complications, including acute renal failure.
- Extended therapy with nitazoxanide (minimum 14 days) may improve patient recovery outcomes.
Background:
Cryptosporidium parvum is a common cause of diarrhea. In immunocompetent individuals, spontaneous recovery is the rule. In immunocompromised patients, it may cause a serious disease. Data on cryptosporidiosis in children after solid organ transplantation are few. We report on 6 pediatric solid organ recipients with gastroenteritis caused by Cryptosporidium.
Patients And Methods:
All episodes of gastroenteritis in solid organ transplant recipients hospitalized in Schneider Children's Medical Center from January 2008 to August 2011 were identified. Data on the episodes with positive staining for Cryptosporidium antigen in stool were reviewed.
Results:
Fifty-seven episodes of gastroenteritis were recorded. In 6 (11%) patients (4 kidney recipient, 1 liver and kidney recipient and 1 heart transplant recipient) Cryptosporidium antigen was detected in stool. Mean age at transplantation was 3.7 ± 2 years, mean time between transplantation and cryptosporidial disease was 39 ± 53.9 months. Symptoms included prolonged diarrhea, fever, abdominal pain and weight loss. Mean duration of symptoms before diagnosis was 10.5 ± 8.7 days. In 5 children, kidney function deteriorated, blood concentrations of tacrolimus increased in 5 patients and abnormal values of liver enzymes were detected in 4 patients. All patients were hospitalized and received intravenous fluid replacement and were treated with nitazoxanide for 5-21 days. Two patients had recurrence of symptoms after short course (5 days) therapy. All patients recovered eventually from the disease.
Conclusion:
Cryptosporidium should be routinely tested in solid organ transplant recipients with diarrhea. Delay in initiation of treatment can result in serious complications including acute renal failure. Long-term therapy with nitazoxanide (at least 14 days) may facilitate recovery.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Fungal Phylum Microsporidia
Kidney Transplant III: Nursing Management
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Excretion

